Country: Canada
Language: English
Source: Health Canada
BETA-CAROTENE; FOLIC ACID; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); ASCORBIC ACID (ASCORBIC ACID); VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE); MAGNESIUM (MAGNESIUM OXIDE); IODINE (POTASSIUM IODIDE); IRON (FERROUS FUMARATE); COPPER (CUPRIC OXIDE); ZINC (ZINC OXIDE); VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE)
DUCHESNAY INC
B03AE04
IRON, MULTIVITAMINS AND MINERALS
1.6MG; 5MG; 13.8MG; 120MG; 3MG; 3.4MG; 20MG; 10MG; 5MG; 50MG; 0.15MG; 35MG; 2MG; 15MG; 12MCG; 600UNIT; 300MG
TABLET
BETA-CAROTENE 1.6MG; FOLIC ACID 5MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; ASCORBIC ACID (ASCORBIC ACID) 120MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; IODINE (POTASSIUM IODIDE) 0.15MG; IRON (FERROUS FUMARATE) 35MG; COPPER (CUPRIC OXIDE) 2MG; ZINC (ZINC OXIDE) 15MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 600UNIT; CALCIUM (CALCIUM CARBONATE) 300MG
ORAL
30 PINK AND 30 BLUE TABLETS
Prescription
VITAMINS & MINERALS
Active ingredient group (AIG) number: 1747661006; AHFS:
APPROVED
2016-01-26
_ _ _Pregvit_ _®_ _ and Pregvit_ _®_ _ folic 5Product Monograph _ _Page 1 of 39 _ _ _ PRODUCT MONOGRAPH Pr PREGVIT ® Vitamin-Mineral Supplement Tablets For Prenatal/Postpartum Use Pr PREGVIT ® FOLIC 5 Vitamin-Mineral Supplement Tablets High Dose Folic Acid for Prenatal Use Multivitamins and other Minerals Including Combinations Duchesnay Inc. 950 boul. Michèle-Bohec Blainville, Québec Canada, J7C 5E2 www.duchesnay.com © 2015 Duchesnay Inc. Duchesnay Inc. Patents: Canada 2,478,163; 2,478,278 (Other Patents Pending Worldwide) Date of Revision: January 26, 2016 Control No.: 183056 _ _ _Pregvit_ _®_ _ and Pregvit_ _®_ _ folic 5Product Monograph _ _Page 2 of 39 _ _ _ _ _ _ _ _Pregvit_ _®_ _ and Pregvit_ _®_ _ folic 5Product Monograph _ _Page 3 of 39 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 4 SUMMARY PRODUCT INFORMATION .............................................................................................................. 3 INDICATIONS AND CLINICAL USE .................................................................................................................... 5 CONTRAINDICATIONS ......................................................................................................................................... 6 WARNINGS AND PRECAUTIONS ........................................................................................................................ 6 ADVERSE REACTIONS ......................................................................................................................................... 8 DRUG INTERACTIONS ........................................................................................................................................ 11 DOSAGE AND ADMINISTRATION .................................................................................................................... 16 OVERDOSAGE .................................................................. Read the complete document